Viemed Healthcare, Inc. announced its financial results for the second quarter ended June 30, 2025, reporting record quarterly revenue of $63.1 million. This represents a 14.7% increase over net revenues reported for the comparable quarter ended June 30, 2024. GAAP earnings per share reached $0.08, and net income attributable to shareholders more than doubled year-over-year to $3.2 million.
Adjusted EBITDA grew by 11.5% year-over-year, reflecting underlying operating strength. The company saw significant patient volume increases, with ventilator patient count rising 11.4% to 12,152 and PAP therapy patients jumping 51.4% to 26,260 as of June 30, 2025. Sleep resupply also increased by 25.1% year-over-year.
Following these results and the recent acquisition of Lehan's Medical Equipment, management raised its full-year 2025 financial guidance. Net revenue guidance was increased to a range of $271 million to $277 million, and Adjusted EBITDA guidance was raised to between $59 million and $62 million. This updated outlook primarily includes Lehan's anticipated results for the second half of 2025.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.